Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Benedetti

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 28, 2020
Olive leaf extract impairs mitochondria by pro-oxidant activity in MDA-MB-231 and OVCAR-3 cancer cellsReyes Benot-Dominguez, Maria Grazia Tupone, Vanessa Castelli, et al.
Journal of Cellular Physiology|July 16, 2017
Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epitheliumLaura Brandolini, Michele d'Angelo, Andrea Antonosante, et al.
Journal of Cellular Physiology|May 11, 2017
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and CorbarinoDaniela Barone, Letizia Cito, Giuseppina Tommonaro, et al.
Journal of Cellular Physiology|May 13, 2016
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New DrugsAnnamaria Cimini, Michele d'Angelo, Elisabetta Benedetti, et al.
Oncotarget|October 31, 2015
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modellingLaura Brandolini, Loredana Cristiano, Alessia Fidoamore, et al.
Oncotarget|November 6, 2015
Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor modelElisabetta Benedetti, Andrea Antonosante, Michele d'Angelo, et al.
Journal of Cellular Physiology|October 14, 2016
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary CellsElisabetta Benedetti, Michele d'Angelo, Alessandra Ammazzalorso, et al.
Journal of Cellular Physiology|September 24, 2017
Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolinAnne-Chloé Dhez, Elisabetta Benedetti, Andrea Antonosante, et al.
Cell Death & Disease|May 25, 2022
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactionsLaura Brandolini, Michele d'Angelo, Rubina Novelli, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 28, 2020
Olive leaf extract impairs mitochondria by pro-oxidant activity in MDA-MB-231 and OVCAR-3 cancer cellsReyes Benot-Dominguez, Maria Grazia Tupone, Vanessa Castelli, et al.
Journal of Cellular Physiology|July 16, 2017
Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epitheliumLaura Brandolini, Michele d'Angelo, Andrea Antonosante, et al.
Journal of Cellular Physiology|May 11, 2017
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and CorbarinoDaniela Barone, Letizia Cito, Giuseppina Tommonaro, et al.
Journal of Cellular Physiology|May 13, 2016
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New DrugsAnnamaria Cimini, Michele d'Angelo, Elisabetta Benedetti, et al.
Oncotarget|October 31, 2015
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modellingLaura Brandolini, Loredana Cristiano, Alessia Fidoamore, et al.
Oncotarget|November 6, 2015
Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor modelElisabetta Benedetti, Andrea Antonosante, Michele d'Angelo, et al.
Journal of Cellular Physiology|October 14, 2016
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary CellsElisabetta Benedetti, Michele d'Angelo, Alessandra Ammazzalorso, et al.
Journal of Cellular Physiology|September 24, 2017
Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolinAnne-Chloé Dhez, Elisabetta Benedetti, Andrea Antonosante, et al.
Cell Death & Disease|May 25, 2022
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactionsLaura Brandolini, Michele d'Angelo, Rubina Novelli, et al.
Pageof 8